Ferri, CP, Prince, M, Brayne, C, Brodaty, H, Fratiglioni, L, Ganguli, M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet
2005; 366: 2112–7.
Bruscoli, M, Lovestone, S. Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr
2004; 16: 129–40.
Yaffe, K, Blackwell, T, Kanaya, AM, Davidowitz, N, Barrett-Connor, E, Krueger, K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology
2004; 63: 658–63.
Luchsinger, JA, Reitz, C, Patel, B, Tang, MX, Manly, JJ, Mayeux, R. Relation of diabetes to mild cognitive impairment. Arch Neurol
2007; 64: 570–5.
Biessels, GJ, Staekenborg, S, Brunner, E, Brayne, C, Scheltens, P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol
2006; 5: 64–74.
Biessels, GJ, Deary, IJ, Ryan, CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol
2008; 7: 184–90.
Das, SK, Bose, P, Biswas, A, Dutt, A, Banerjee, TK, Hazra, AM, et al. An epidemiologic study of mild cognitive impairment in Kolkata, India. Neurology
2007; 68: 2019–26.
Zimmet, P, Alberti, KG, Shaw, J. Global and societal implications of the diabetes epidemic. Nature
2001; 414: 782–7.
Ellul, J, Archer, N, Foy, CM, Poppe, M, Boothby, H, Nicholas, H, et al. The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration. J Neurol Neurosurg Psychiatry
2007; 78: 233–9.
Hye, A, Lynham, S, Thambisetty, M, Causevic, M, Campbell, J, Byers, HL, et al. Proteome-based plasma biomarkers for Alzheimer's disease. Brain
2006; 129: 3042–50.
Folstein, MF, Folstein, SE, McHugh, PR. ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res
1975; 12: 189–98.
Morris, JC, Mohs, RC, Rogers, H, Fillenbaum, G, Heyman, A. Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull
1988; 24: 641–52.
Nelson, HE. National Adult Reading Test. Test Manual. NferNelson, 1982.
Petersen, RC, Smith, GE, Waring, SC, Ivnik, RJ, Tangalos, EG, Kokmen, E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol
1999; 56: 303–8.
Lopez, OL, Jagust, WJ, DeKosky, ST, Becker, JT, Fitzpatrick, A, Dulberg, C, et al. Prevalence and classification of mild cognitive impairment in the cardiovascular health study cognition study. Arch Neurol
2003; 60: 1385–9.
Wenham, PR, Price, WH, Blandell, G. Apolipoprotein E genotyping by one-stage PCR. Lancet
1991; 337: 1158–9.
Yesavage, JA, Brink, TL, Rose, TL, Lum, O, Huang, V, Adey, M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res
1983; 17: 37–49.
De Jager, CA, Budge, MM, Clarke, R. Utility of TICS–M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry
2003; 18: 318–24.
Foy, CM, Nicholas, H, Hollingworth, P, Boothby, H, Williams, J, Brown, RG, et al. Diagnosing Alzheimer's disease – non-clinicians and computerised algorithms together are as accurate as the best clinical practice. Int J Geriatr Psychiatry
2007; 22: 1154–63.
Roth, M, Tym, E, Mountjoy, CQ, Huppert, FA, Hendrie, H, Verma, S, Goddard, R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry
1986; 149: 698–709.
Blessed, G, Tomlinson, BE, Roth, M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry
1968; 114: 797–811.
Bucks, RS, Ashworth, DL, Wilcock, GK, Siegfried, K. Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. Age Ageing
1996; 25: 113–20.
Cummings, JL, Mega, M, Gray, K, Rosenberg-Thompson, S, Carusi, DA, Gornbein, J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology
1994; 44: 2308–14.
Alexopoulos, GS, Abrams, RC, Young, RC, Shamoian, CA. Cornell Scale for Depression in Dementia. Biol Psychiatry
1988; 23: 271–84.
Webster, DD. Critical analysis of the disability in Parkinson's disease. Mod Treat
1968; 5: 257–82.
Fischer, P, Jungwirth, S, Zehetmayer, S, Weissgram, S, Hoenigschnabl, S, Gelpi, E, et al. Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology
2007; 68: 288–91.
Yaffe, K, Petersen, RC, Lindquist, K, Kramer, J, Miller, B. Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord
2006; 22: 312–9.
Roberts, RO, Geda, YE, Knopman, DS, Christianson, TJ, Pankratz, VS, Boeve, BF, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol
2008; 65: 1066–73.
Fillit, H, Nash, DT, Rundek, T, Zuckerman, A. Cardiovascular risk factors and dementia. Am J Geriatr Pharmacother
2008; 6: 100–18.
Barabash, A, Marcos, A, Ancín, I, Vázquez-Alvarez, B, de Ugarte, C, Gil, P, et al. APOE, ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol Aging
2009; 30: 1254–64.